Also, Mirazchi et al. demonstrated more effective tumor growth reduction, tumor delivery, and lower toxicity of Fucoidan-made nanoparticles encapsulating the PI3K inhibitor BYL719 and targeted with P-selectin in the patient’s derived xenografts of NSCLC compared to free BYL719 [50]. The gene discussed is SELP; the disease is neoplasm.